ATLAS / Macro Radar / Reporting / INKT

MiNK Therapeutics, Inc. (INKT) reporting calendar

MiNK Therapeutics, Inc. files periodic reports with the SEC as INKT on Nasdaq. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 6 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open INKT market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001193125-26-226804
10-K31 Dec 202531 Mar 202690 days0001193125-26-134813
10-Q30 Sep 202514 Nov 202545 days0001193125-25-282905
10-Q30 Jun 202514 Aug 202545 days0000950170-25-108894
10-Q31 Mar 202515 May 202545 days0000950170-25-072789
10-K31 Dec 202418 Mar 202577 days0000950170-25-041379
10-Q30 Sep 202414 Nov 202445 days0000950170-24-127033
10-Q30 Jun 202413 Aug 202444 days0000950170-24-096142
10-Q31 Mar 202414 May 202444 days0000950170-24-059081
10-K31 Dec 202321 Mar 202481 days0000950170-24-034672
10-Q30 Sep 202314 Nov 202345 days0000950170-23-063851
10-Q30 Jun 202310 Aug 202341 days0000950170-23-040958
10-Q31 Mar 202311 May 202341 days0000950170-23-021191
10-K31 Dec 202224 Mar 202383 days0000950170-23-009762
10-Q30 Sep 20223 Nov 202234 days0000950170-22-021565
10-Q30 Jun 202215 Aug 202246 days0001564590-22-029503
10-Q31 Mar 202213 May 202243 days0001564590-22-020146
10-K31 Dec 202118 Mar 202277 days0001564590-22-011026
10-Q30 Sep 202129 Nov 202160 days0001564590-21-058700

Source: SEC EDGAR company submissions for CIK 0001840229. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.